Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery-Reference-Cited by-同舟云学术

Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery

Published:2021-12-17 Issue:4 Volume:125 Page:782-789
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:Journal of Surgical Oncology

Author:

Congedo Maria Teresa¹^ORCID,Nachira Dania¹,Bertolaccini Luca²^ORCID,Chiappetta Marco¹,Zanfrini Edoardo¹,Meacci Elisa¹,Vita Maria Letizia¹,Lococo Filippo¹,D'Argento Ettore³,Spaggiari Lorenzo²,Margaritora Stefano¹

Affiliation:

1. Department of Thoracic Surgery Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore Rome Italy

2. Department of Thoracic Surgery IEO, European Institute of Oncology IRCCS Milan Italy

3. Department of Medical Oncology , Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Università Cattolica del Sacro Cuore Rome Italy

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26773

Reference28 articles.

1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

2. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system

3. The IASLC Lung Cancer Staging Project

4. Surgical treatment of oligometastatic non-small cell lung cancer

5. Non-small cell lung cancer with single brain metastasis: the role of surgical treatment

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Benefits of Primary Tumor Surgery in Diverse Cancer Types with Synchronous Bone Metastases: A Retrospective Real-World Analysis Using Propensity Score Matching from a 3P Medicine Perspective;2023-12-13

2. Genomic features and its potential implication in bone oligometastatic NSCLC;BMC Pulmonary Medicine;2023-02-08

3. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2;Open Life Sciences;2023-01-01